Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Not Confirmed
Not Confirmed
01 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
01-03 September, 2025
Process DevelopmentProcess Development
Industry Trade Show
Not Confirmed
01 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
26 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/26/3139154/0/en/Altimmune-to-Participate-in-Upcoming-Investor-Conferences.html
19 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/19/3135602/0/en/Altimmune-Announces-FDA-Fast-Track-Designation-for-Pemvidutide-in-Alcohol-Use-Disorder-AUD.html
12 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/12/3131554/0/en/Altimmune-Announces-Second-Quarter-2025-Financial-Results-and-Business-Update.html
09 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/09/3112467/0/en/Altimmune-Announces-Initiation-of-RESTORE-Phase-2-Trial-Evaluating-the-Efficacy-and-Safety-of-Pemvidutide-in-Alcohol-Associated-Liver-Disease-ALD.html
26 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/26/3105697/0/en/Altimmune-Announces-Positive-Topline-Results-from-the-IMPACT-Phase-2b-Trial-of-Pemvidutide-in-the-Treatment-of-MASH.html
25 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/25/3105503/0/en/Altimmune-to-Announce-Topline-24-Week-Results-from-its-IMPACT-Phase-2b-Trial-of-Pemvidutide-in-the-Treatment-of-MASH-on-Thursday-June-26.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE